{"entity":{"type":"insider","cik":"0001753185","url":"/insider/0001753185","json_url":"/insider/0001753185.json","name":"Wedell-Wedellsborg Johan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":16,"first":"2019-08-22","last":"2023-12-12","span_basis":"filed_date"},"name_variants":[{"name":"Wedell-Wedellsborg Johan","source":"filing","n_filings":16,"first_seen":"2019-08-22","last_seen":"2023-12-12"}],"transactions":[{"id":8534633,"accession":"0001104659-23-125199","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-125199","line_url":"/filing/0001104659-23-125199#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6455.0,"shares_display":"6,455","price_per_share":6.8523,"price_display":"6.85","price_state":"stated","total_value":44231.5965,"total_display":"44,231.60","shares_owned_after":4559233.0,"shares_owned_after_display":"4,559,233","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-12","scope":"insider"},{"id":8257056,"accession":"0001104659-23-125054","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-23-125054","line_url":"/filing/0001104659-23-125054#line-3","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":102863.0,"shares_display":"102,863","price_per_share":7.0078,"price_display":"7.01","price_state":"stated","total_value":720843.3314,"total_display":"720,843.33","shares_owned_after":4552778.0,"shares_owned_after_display":"4,552,778","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-11","scope":"insider"},{"id":8257053,"accession":"0001104659-23-125054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-125054","line_url":"/filing/0001104659-23-125054#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18503.0,"shares_display":"18,503","price_per_share":6.9923,"price_display":"6.99","price_state":"stated","total_value":129378.5269,"total_display":"129,378.53","shares_owned_after":4449915.0,"shares_owned_after_display":"4,449,915","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-08","filed_date":"2023-12-11","scope":"insider"},{"id":8257050,"accession":"0001104659-23-125054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-125054","line_url":"/filing/0001104659-23-125054#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6183.0,"shares_display":"6,183","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":40189.5,"total_display":"40,189.50","shares_owned_after":4431412.0,"shares_owned_after_display":"4,431,412","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-07","filed_date":"2023-12-11","scope":"insider"},{"id":8290855,"accession":"0001104659-23-122895","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-122895","line_url":"/filing/0001104659-23-122895#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51837.0,"shares_display":"51,837","price_per_share":5.9702,"price_display":"5.97","price_state":"stated","total_value":309477.2574,"total_display":"309,477.26","shares_owned_after":4425229.0,"shares_owned_after_display":"4,425,229","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-29","filed_date":"2023-12-01","scope":"insider"},{"id":8648832,"accession":"0001104659-23-122095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-122095","line_url":"/filing/0001104659-23-122095#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30671.0,"shares_display":"30,671","price_per_share":5.8125,"price_display":"5.81","price_state":"stated","total_value":178275.1875,"total_display":"178,275.19","shares_owned_after":4373392.0,"shares_owned_after_display":"4,373,392","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-28","filed_date":"2023-11-29","scope":"insider"},{"id":8648830,"accession":"0001104659-23-122095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-122095","line_url":"/filing/0001104659-23-122095#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":62516.0,"shares_display":"62,516","price_per_share":5.4869,"price_display":"5.49","price_state":"stated","total_value":343019.0404,"total_display":"343,019.04","shares_owned_after":4342721.0,"shares_owned_after_display":"4,342,721","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-27","filed_date":"2023-11-29","scope":"insider"},{"id":8472994,"accession":"0001104659-23-061940","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-061940","line_url":"/filing/0001104659-23-061940#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":101740.0,"shares_display":"101,740","price_per_share":9.6462,"price_display":"9.65","price_state":"stated","total_value":981404.388,"total_display":"981,404.39","shares_owned_after":4280205.0,"shares_owned_after_display":"4,280,205","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-17","scope":"insider"},{"id":4130088,"accession":"0001104659-21-080236","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-080236","line_url":"/filing/0001104659-21-080236#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11229.0,"shares_display":"11,229","price_per_share":36.1538,"price_display":"36.15","price_state":"stated","total_value":405971.0202,"total_display":"405,971.02","shares_owned_after":4178465.0,"shares_owned_after_display":"4,178,465","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-10","filed_date":"2021-06-11","scope":"insider"},{"id":4458190,"accession":"0001104659-21-079592","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-079592","line_url":"/filing/0001104659-21-079592#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":116700.0,"shares_display":"116,700","price_per_share":36.1878,"price_display":"36.19","price_state":"stated","total_value":4223116.26,"total_display":"4,223,116.26","shares_owned_after":4189694.0,"shares_owned_after_display":"4,189,694","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-09","filed_date":"2021-06-10","scope":"insider"},{"id":4458185,"accession":"0001104659-21-079592","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-079592","line_url":"/filing/0001104659-21-079592#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33300.0,"shares_display":"33,300","price_per_share":35.2761,"price_display":"35.28","price_state":"stated","total_value":1174694.13,"total_display":"1,174,694.13","shares_owned_after":4306394.0,"shares_owned_after_display":"4,306,394","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-08","filed_date":"2021-06-10","scope":"insider"},{"id":4514527,"accession":"0001104659-21-078949","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-078949","line_url":"/filing/0001104659-21-078949#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72400.0,"shares_display":"72,400","price_per_share":34.1517,"price_display":"34.15","price_state":"stated","total_value":2472583.08,"total_display":"2,472,583.08","shares_owned_after":4339694.0,"shares_owned_after_display":"4,339,694","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-09","scope":"insider"},{"id":4211035,"accession":"0001104659-21-077703","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-077703","line_url":"/filing/0001104659-21-077703#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3841.0,"shares_display":"3,841","price_per_share":34.0286,"price_display":"34.03","price_state":"stated","total_value":130703.8526,"total_display":"130,703.85","shares_owned_after":4412094.0,"shares_owned_after_display":"4,412,094","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-04","filed_date":"2021-06-07","scope":"insider"},{"id":4211030,"accession":"0001104659-21-077703","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-077703","line_url":"/filing/0001104659-21-077703#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30666.0,"shares_display":"30,666","price_per_share":33.1856,"price_display":"33.19","price_state":"stated","total_value":1017669.6096,"total_display":"1,017,669.61","shares_owned_after":4415935.0,"shares_owned_after_display":"4,415,935","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-03","filed_date":"2021-06-07","scope":"insider"},{"id":4409910,"accession":"0001104659-21-075782","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-075782","line_url":"/filing/0001104659-21-075782#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6864.0,"shares_display":"6,864","price_per_share":35.573,"price_display":"35.57","price_state":"stated","total_value":244173.072,"total_display":"244,173.07","shares_owned_after":4446601.0,"shares_owned_after_display":"4,446,601","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-02","scope":"insider"},{"id":4409907,"accession":"0001104659-21-075782","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-075782","line_url":"/filing/0001104659-21-075782#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":36.339,"price_display":"36.34","price_state":"stated","total_value":908475.0,"total_display":"908,475.00","shares_owned_after":4453465.0,"shares_owned_after_display":"4,453,465","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-28","filed_date":"2021-06-02","scope":"insider"},{"id":7943606,"accession":"0001104659-19-049317","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-049317","line_url":"/filing/0001104659-19-049317#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5791.0,"shares_display":"5,791","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":156357.0,"total_display":"156,357.00","shares_owned_after":498392.0,"shares_owned_after_display":"498,392","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-06","filed_date":"2019-09-09","scope":"insider"},{"id":7943601,"accession":"0001104659-19-049317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-049317","line_url":"/filing/0001104659-19-049317#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11452.0,"shares_display":"11,452","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":309204.0,"total_display":"309,204.00","shares_owned_after":504183.0,"shares_owned_after_display":"504,183","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-05","filed_date":"2019-09-09","scope":"insider"},{"id":8054120,"accession":"0001104659-19-048440","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-048440","line_url":"/filing/0001104659-19-048440#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":2700.0,"total_display":"2,700.00","shares_owned_after":515635.0,"shares_owned_after_display":"515,635","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-30","filed_date":"2019-09-03","scope":"insider"},{"id":8054116,"accession":"0001104659-19-048440","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-048440","line_url":"/filing/0001104659-19-048440#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89066.0,"shares_display":"89,066","price_per_share":26.58,"price_display":"26.58","price_state":"stated","total_value":2367374.28,"total_display":"2,367,374.28","shares_owned_after":515735.0,"shares_owned_after_display":"515,735","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-29","filed_date":"2019-09-03","scope":"insider"},{"id":7995724,"accession":"0001104659-19-047982","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-047982","line_url":"/filing/0001104659-19-047982#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29552.0,"shares_display":"29,552","price_per_share":27.02,"price_display":"27.02","price_state":"stated","total_value":798495.04,"total_display":"798,495.04","shares_owned_after":604801.0,"shares_owned_after_display":"604,801","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-28","filed_date":"2019-08-29","scope":"insider"},{"id":7995719,"accession":"0001104659-19-047982","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-047982","line_url":"/filing/0001104659-19-047982#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19805.0,"shares_display":"19,805","price_per_share":27.18,"price_display":"27.18","price_state":"stated","total_value":538299.9,"total_display":"538,299.90","shares_owned_after":634353.0,"shares_owned_after_display":"634,353","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-27","filed_date":"2019-08-29","scope":"insider"},{"id":8510510,"accession":"0001104659-19-047287","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-047287","line_url":"/filing/0001104659-19-047287#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":990.0,"shares_display":"990","price_per_share":27.75,"price_display":"27.75","price_state":"stated","total_value":27472.5,"total_display":"27,472.50","shares_owned_after":654158.0,"shares_owned_after_display":"654,158","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-22","filed_date":"2019-08-26","scope":"insider"},{"id":9223458,"accession":"0001104659-19-047283","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-047283","line_url":"/filing/0001104659-19-047283#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60116.0,"shares_display":"60,116","price_per_share":27.83,"price_display":"27.83","price_state":"stated","total_value":1673028.28,"total_display":"1,673,028.28","shares_owned_after":655148.0,"shares_owned_after_display":"655,148","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-21","filed_date":"2019-08-26","scope":"insider"},{"id":8093550,"accession":"0001104659-19-046923","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-046923","line_url":"/filing/0001104659-19-046923#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60116.0,"shares_display":"60,116","price_per_share":27.83,"price_display":"27.83","price_state":"stated","total_value":1673028.28,"total_display":"1,673,028.28","shares_owned_after":664147.0,"shares_owned_after_display":"664,147","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-21","filed_date":"2019-08-22","scope":"insider"},{"id":9223459,"accession":"0001104659-19-047283","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-047283","line_url":"/filing/0001104659-19-047283#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":108128.0,"shares_display":"108,128","price_per_share":27.42,"price_display":"27.42","price_state":"stated","total_value":2964869.76,"total_display":"2,964,869.76","shares_owned_after":715264.0,"shares_owned_after_display":"715,264","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-26","scope":"insider"},{"id":8093548,"accession":"0001104659-19-046923","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-046923","line_url":"/filing/0001104659-19-046923#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753185","owner_name":"Wedell-Wedellsborg Johan","owner_url":"/insider/0001753185","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":108128.0,"shares_display":"108,128","price_per_share":27.42,"price_display":"27.42","price_state":"stated","total_value":2964869.76,"total_display":"2,964,869.76","shares_owned_after":724263.0,"shares_owned_after_display":"724,263","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-22","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":27,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":27},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001722964","name":"Y-mAbs Therapeutics, Inc.","url":"/issuer/0001722964","role":"Director, Ten percent owner","n_filings":16,"first_seen":"2019-08-22","last_seen":"2023-12-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001753185","retrieved_at":"2026-08-21T16:50:52+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}